Jesse Shefferman
CIK: 0001799167
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Protara Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Jun 30, 2026TARA
Protara Therapeutics, Inc.
Gift(G)Direct4K shares- - Jun 30, 2026TARA
Protara Therapeutics, Inc.
Gift(G)Direct5K shares- - Jun 30, 2026TARA
Protara Therapeutics, Inc.
Gift(G)Direct7K shares- - Jun 30, 2026TARA
Protara Therapeutics, Inc.
Gift(G)Direct14K shares- - Jun 29, 2026TARA
Protara Therapeutics, Inc.
Exercise(M)Direct215.7K shares at avg. $1.91$412K - Jun 29, 2026TARA
Protara Therapeutics, Inc.
Sale(S)Direct215.7K shares at avg. $4.09$882K - Jan 26, 2026TARA
Protara Therapeutics, Inc.
Tax Payment(F)Direct8.7K shares at avg. $6.67$58K - Jan 20, 2026TARA
Protara Therapeutics, Inc.
Tax Payment(F)Direct16.3K shares at avg. $5.60$91K - Jan 16, 2026TARA
Protara Therapeutics, Inc.
Award(A)Direct87K shares- - Jun 27, 2025TARA
Protara Therapeutics, Inc.
Gift(G)Direct3.4K shares- - Jun 27, 2025TARA
Protara Therapeutics, Inc.
Gift(G)Direct10.2K shares- - Jun 26, 2025TARA
Protara Therapeutics, Inc.
Gift(G)Direct1.7K shares- - Jun 26, 2025TARA
Protara Therapeutics, Inc.
Gift(G)Direct3.4K shares- - Jun 24, 2025TARA
Protara Therapeutics, Inc.
Gift(G)Direct300K shares- - Jan 24, 2025TARA
Protara Therapeutics, Inc.
Award(A)Direct65K shares- - Jan 21, 2025TARA
Protara Therapeutics, Inc.
Tax Payment(F)Direct15.5K shares at avg. $4.76$74K - Jan 3, 2025TARA
Protara Therapeutics, Inc.
Tax Payment(F)Direct6.5K shares at avg. $6.14$40K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | TARA Protara Therapeutics, Inc. | Gift(G) | 4,000 | - | $0 | Direct |
| Jun 30, 2026 | TARA Protara Therapeutics, Inc. | Gift(G) | 5,000 | - | $0 | Direct |
| Jun 30, 2026 | TARA Protara Therapeutics, Inc. | Gift(G) | 7,000 | - | $0 | Direct |
| Jun 30, 2026 | TARA Protara Therapeutics, Inc. | Gift(G) | 14,000 | - | $0 | Direct |
| Jun 29, 2026 | TARA Protara Therapeutics, Inc. | Exercise(M) | 215,687 | $1.91 | $411,962 | Direct |
| Jun 29, 2026 | TARA Protara Therapeutics, Inc. | Sale(S) | 215,687 | $4.09 | $882,160 | Direct |
| Jan 26, 2026 | TARA Protara Therapeutics, Inc. | Tax Payment(F) | 8,732 | $6.67 | $58,242 | Direct |
| Jan 20, 2026 | TARA Protara Therapeutics, Inc. | Tax Payment(F) | 16,322 | $5.60 | $91,403 | Direct |
| Jan 16, 2026 | TARA Protara Therapeutics, Inc. | Award(A) | 87,000 | - | $0 | Direct |
| Jun 27, 2025 | TARA Protara Therapeutics, Inc. | Gift(G) | 3,367 | - | - | Direct |
| Jun 27, 2025 | TARA Protara Therapeutics, Inc. | Gift(G) | 10,200 | - | - | Direct |
| Jun 26, 2025 | TARA Protara Therapeutics, Inc. | Gift(G) | 1,700 | - | - | Direct |
| Jun 26, 2025 | TARA Protara Therapeutics, Inc. | Gift(G) | 3,400 | - | - | Direct |
| Jun 24, 2025 | TARA Protara Therapeutics, Inc. | Gift(G) | 300,000 | - | - | Direct |
| Jan 24, 2025 | TARA Protara Therapeutics, Inc. | Award(A) | 65,000 | - | $0 | Direct |
| Jan 21, 2025 | TARA Protara Therapeutics, Inc. | Tax Payment(F) | 15,469 | $4.76 | $73,632 | Direct |
| Jan 3, 2025 | TARA Protara Therapeutics, Inc. | Tax Payment(F) | 6,479 | $6.14 | $39,781 | Direct |
1-17 of 17 transactions
About Shefferman Jesse
Shefferman Jesse (SEC CIK 0001799167) files insider reports with the SEC as CEO and President of Protara Therapeutics, Inc. (TARA).
Signal8 holds 10 ownership filings by Shefferman Jesse, all Form 4s, filed between Jan 7, 2025 and Jul 1, 2026. Those filings report 17 transactions, from Jan 3, 2025 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Shefferman Jesse's filings is in NEW YORK, NY.
Recent filings by Shefferman Jesse
- Jun 30, 2026: Gifts of TARA shares (4 lines, Form 4, code G).
- Jun 29, 2026: Option exercise of TARA shares (Form 4, code M).
- Jun 29, 2026: Open-market sale of TARA shares (Form 4, code S).
- Jan 26, 2026: Tax withholding of TARA shares (Form 4, code F).
- Jan 20, 2026: Tax withholding of TARA shares (Form 4, code F).
Other insiders filing for Protara Therapeutics, Inc. (TARA)
- Levy Richard S, Director
- Solomon Michael Edward, Director
- Smith Cynthia, Director
- SARGEN GREGORY, Director
- Huang Jane, Director
- GARCEAU ROGER, Director